Last updated 2026-06-18
- Raised $8.3M funding round led by S2G Investments, Sep 2023
- Raised $4.3M funding round, Jun 2021
- Raised $2.5M funding round, Jul 2018
Total raised
$16.1M
Last: 2023-09
Stage
Seed
Founded
2014
Headcount
13
HQ
Kadima Zoran, Israel
Sector
Agriculture & Food Technologies
About
ViAqua Therapeutics is the developer of an orally administered treatment designed to improve health management and prevent viral epidemics in aquaculture. The company's first product is designed for use in shrimp, which comprises 20% of the total international trade value of fish products. ViAqua's platform for health management in shellfish and fish utilizes a proprietary RNAi formulation that triggers the immune system and prevents viral infections. The coated particles are delivered via feed to produce the maximum effect and reduce cost.
Funding history · 5 rounds · $16.1M total
2023-09
2021-06
2018-07
$2.5M
2014-09
Date unknown
Grant
Undisclosed
Q&A
- What is ViAqua Therapeutics' primary focus?
- ViAqua Therapeutics develops an orally administered treatment to improve health management and prevent viral epidemics in aquaculture, with its first product targeting shrimp.
- When was ViAqua Therapeutics founded?
- ViAqua Therapeutics was founded in September 2014.
- What is ViAqua Therapeutics' total funding to date?
- ViAqua Therapeutics has raised a total of $16,050,000 in funding.
- Which investors participated in ViAqua Therapeutics' September 2023 funding round?
- In September 2023, ViAqua Therapeutics raised $8,250,000 in a round led by.
- What is the employee count for ViAqua Therapeutics?
- ViAqua Therapeutics has an employee count in the 11-50 range.
- What is the core technology of ViAqua Therapeutics' platform?
- ViAqua Therapeutics' platform utilizes a proprietary RNAi formulation delivered via feed to trigger the immune system and prevent viral infections in shellfish and fish.
- Who are the co-founders of ViAqua Therapeutics?
- The co-founders of ViAqua Therapeutics are Shai Ufaz, who also serves as CEO, and Shai Einbinder.
- What was the amount and lead investors of ViAqua Therapeutics' June 2021 funding round?
- In June 2021, ViAqua Therapeutics raised $4,300,000. Investors included S2G Investments and Thai Union Group.
Team · 2
Sectors & technology
Primary sector
Agriculture & Food Technologies
Sub-sectors
Climate TechFood & Land UseSustainable FarmingHealth Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Technologies
Biologicals
Target customers
Agriculture & FoodMarine LifeFishSea Food
Business model
B2B
Highlights
Verified
Tags
sustainable-farmingtherapeuticsviral-diseasesfish-farmsagtechaquacultureclimate-techdrug-deliveryfarmersagriculturedisease-management
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | viaqua-t.com |
|---|---|
| linkedin.com/company/34752747 |
Identifiers & details
| Founded | 2014-9 |
|---|---|
| Employees (exact) | 13 |
| Offices | Haifa |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | viaqua-t.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|